I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: TIZIANA LIFE SC ORD 3P TILS Announcements

TIZIANA LIFE SC ORD 3P (TILS) Announcements

Date Time Source Announcement
20 Nov 2018 7:00 am
RNS
Offer Pricing, Nasdaq Listing & Loan Conversion
26 Oct 2018 5:30 pm
RNS
Issue of Equity
18 Oct 2018 7:15 am
RNS
Amended Registration Statement filed with the SEC
16 Oct 2018 7:00 am
RNS
Milciclib synergistic activity presented at AASLD
25 Sep 2018 7:00 am
RNS
Tiziana announces Offering & Application to Nasdaq
24 Sep 2018 7:03 am
RNS
Interim Results for Six Months Ended 30 June 2018
  7:00 am
RNS
U.S. FDA Approval IND Nasal Foralumab Phase 1
13 Sep 2018 1:05 pm
RNS
PDMR Dealing
12 Sep 2018 7:00 am
RNS
PDMR dealings
11 Sep 2018 7:00 am
RNS
PDMR Dealing
24 Aug 2018 7:00 am
RNS
PDMR Dealing
21 Aug 2018 7:00 am
RNS
PDMR dealings
20 Aug 2018 7:00 am
RNS
PDMR Dealing
17 Aug 2018 7:00 am
RNS
PDMR Dealing
16 Aug 2018 9:00 am
RNS
Filing of Investigational New Drug application
27 Jul 2018 7:00 am
RNS
US Registration Statement for Proposed Offering
25 Jun 2018 10:49 am
RNS
Result of AGM
07 Jun 2018 7:01 am
RNS
Appointment of Broker
  7:00 am
RNS
Final Results
01 Jun 2018 7:00 am
RNS
Notice of AGM
23 May 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
16 May 2018 7:00 am
RNS
Milciclib Phase 2a Trial - Tolerability Update
01 May 2018 3:00 pm
RNS
Grant of Options - Director Dealing
27 Apr 2018 7:00 am
RNS
Issue of Equity
19 Apr 2018 7:00 am
RNS
Subscription
16 Apr 2018 7:25 am
RNS
License Agreement
09 Apr 2018 8:25 am
RNS
Presentation at ASCO 3 June 2018
05 Apr 2018 7:00 am
RNS
Appointment of Broker
04 Apr 2018 7:00 am
RNS
Appointment of Director
05 Mar 2018 7:00 am
RNS
Placing to raise �600,000 and issue of equity
02 Mar 2018 12:09 pm
RNS
Statement re broker
22 Jan 2018 7:00 am
RNS
Placing
16 Jan 2018 7:00 am
RNS
Placing
15 Dec 2017 7:00 am
RNS
Placing and Issue of Equity
08 Dec 2017 7:00 am
RNS
Milciclib Phase 2a Trial Update
27 Nov 2017 7:00 am
RNS
Placing
23 Nov 2017 7:00 am
RNS
Phase II Clinical Trial Update
20 Nov 2017 7:00 am
RNS
Subscription
29 Sep 2017 7:00 am
RNS
Interim Results for Six Months Ended 30 June 2017
06 Sep 2017 7:00 am
RNS
A Proprietary Oral Formulation of Foralumab
31 Aug 2017 11:07 am
RNS
Grant of options - Director's dealing
16 Aug 2017 7:00 am
RNS
Conversion of outstanding loan notes
28 Jul 2017 7:00 am
RNS
Publication of Research Article on Foralumab
19 Jul 2017 7:00 am
RNS
Initiation of a Phase IIa Clinical Trial
12 Jul 2017 7:00 am
RNS
Proposed changes to CLNs and Warrant Terms
29 Jun 2017 11:21 am
RNS
Result of AGM
12 Jun 2017 7:00 am
RNS
Appointment of Dr Kunwar Shailubhai as CEO
08 Jun 2017 10:02 am
RNS
NOTIFICATION OF MAJOR INTEREST IN SHARES
  8:14 am
RNS
Bcl-3 pre-clinical update and Director's dealing
01 Jun 2017 7:00 am
RNS
2016 Annual Report and Accounts and notice of AGM
23 May 2017 7:00 am
RNS
Financial Results for Year Ended 31 December 2016
24 Apr 2017 7:14 am
RNS
Announces Approval of a Phase II Clinical Trial
21 Apr 2017 7:00 am
RNS
Announces Publication of Milciclib Clinical Trial
24 Mar 2017 7:00 am
RNS
Exercise of Warrants & Issue of Equity
14 Mar 2017 7:00 am
RNS
Arun Sanyal appointed to Scientific Advisory Board
16 Jan 2017 7:00 am
RNS
Warrant Expiry - Reminder
03 Jan 2017 7:00 am
RNS
Tiziana Life Sciences in-licenses NI-1201
16 Nov 2016 7:00 am
RNS
New Data with Foralumab
07 Nov 2016 12:29 pm
RNS
Grant of options
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close